-
4m 48sPart 1 | Session 4 IN.PACT AV ACCESS: Outcomes to Date
-
8m 14sPart 1 | Session 5 TINTIN: Combination DCB and Bare Metal Stents In PAD: 4 Year Outcomes
-
7m 13sPart 1 | Session 6 POPCORN Registry: DCB Treatment for Peripheral Artery Disease
-
3m 49sPart 1 | Session 7 MOTIV Bioresorbable Scaffold in BTK Lesions
-
6m 6sPart 1 | Session 8 Improving Clinical Outcomes in Infrapopliteal Lesions With Cre8™ BTK
-
8m 56sPart 1 | Session 9 LIFE-BTK: Esprit BTK System in Narrowed Infrapopliteal Lesions
-
5m 2sPart 1 | Session 1 AVPAS: Lutonix AV Post-Approval Study
-
5m 18sPart 1 | Session 2 The ELEGANCE Registry: Ranger DCB In Under-Represented Groups
LINC 23 - Dr Marianne Brodmann (Medical University of Graz, AT) joins us to discuss the findings from the RANGER II SFA Trial, originally presented at LINC's 2023 scientific sessions. The RANGER trial set out to evaluate the safety and effectiveness of the Ranger™ Paclitaxel Coated Balloon in treating lesions in the superficial femoral and proximal popliteal arteries. This trial enrolled a cohort of 440 patients.
In this interview, Dr Brodmann reveals the long-term efficacy results. These suggested that the Ranger device had an efficient outcome in regard to target lesion revascularisation at both 3 and 4 years.
Interview Questions:
- Tell us about the device investigated in this trial and its unique features.
- What was the patient cohort and study design?
- What are the key findings revealed at LINC 23?
- Are there any patient groups that could benefit more from the use of this DCB?
- What further research is still required?
- What are the next steps?
Recorded remotely from Graz, 2023.
Editor: Jordan Rance
Video Specialist: Dan Brent
Short, accessible Expert Interviews will be available with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Expert Interviews
Short, accessible Expert Interviews with select faculty focusing on the results, applicability, and impact on future research.
Faculty Biographies
Marianne Brodmann
Professor, Head of the Clinical Division of Angiology
Marianne Brodmann is an Austrian physician and academic specializing in angiology and vascular medicine. She has spent her professional career in Austria, where she has combined clinical leadership with an active role in international cardiovascular and vascular research. Her work has focused on advancing the diagnosis and treatment of peripheral vascular disease through both clinical innovation and research.
Academic History
Dr Brodmann trained in internal medicine and angiology, developing expertise in vascular biology, thrombosis, and endovascular therapies. She has been appointed to senior academic and clinical positions at the Medical University of Graz, Austria, where she has contributed extensively to medical education, research, and specialist training in angiology.
Career Overview
Dr Brodmann serves as Head of the Division of Angiology and Head of Clinical Research within the Division of Angiology at the Medical…
Comments